Week 5 Male Reproductive Voiceover PPT

MALE REPRODUCTIVE SYSTEM

Overview

  • Presenter: Dr. Claire Loden, DNP, FNP-C

  • Related Chapters:

    • Chapter 49: Management of Patients with Urinary Disorders

    • Chapter 53: Assessment and Management of Patients with Male Reproductive Disorders


Page 2: Inspirational Quote

  • Fall in love with Jesus

  • Quote: "The Lord is my shepherd; I shall not want." - Psalm 23:1


Page 3: Learning Objectives

  • Understand the disease process, nursing considerations, and interventions.

  • Identify appropriate treatment methods and pharmacotherapy interventions.

  • Identify appropriate patient education discussion points for each disease process.


Page 4: Lecture Topics

  • Acute Prostatitis

  • Benign Prostatic Hypertrophy (BPH)

  • Prostate Cancer

  • Testicular Cancer

  • Orchitis

  • Epididymitis

  • Testicular Torsion

  • Erectile Dysfunction

  • Priapism

  • Bladder Cancer


Page 5: Review of Male Anatomy

  • Key Structures:

    • Symphysis pubis

    • Vas deferens

    • Corpus cavernosum

    • Urinary bladder

    • Ampulla

    • Seminal vesicle

    • Ejaculatory duct

    • Prostate gland

    • Bulbourethral gland

    • Anus

    • Perineum

    • Penis

    • Urethra

    • Glans penis

    • Prepuce

    • Urethral meatus

    • Scrotum

    • Epididymis


Page 6: Acute Prostatitis

  • Definition: Painful inflammation of the prostate.

  • Key Highlights:

    • Most frequent urologic diagnosis in men < 50 years old

    • Commonly caused by E. Coli

    • Symptoms include abdominal, ejaculatory, rectal, and perineal pain.


Page 7: Symptoms of Acute Prostatitis

  • Common Symptoms:

    • Sudden fever

    • Discomfort

    • Burning/urgency

    • Frequent urination

    • Pain with ejaculation

    • Referred pain in genitalia, perineum, lower back, or suprapubic areas.


Page 8: Diagnosis and Treatment of Acute Prostatitis

  • Diagnosis:

    • Urinalysis (UA) & culture (CS)

    • Transrectal ultrasound (to rule out abscess, cysts, or seminal vesicle obstruction).

  • Treatment:

    • Antibiotics: Ciprofloxacin or Bactrim

    • NSAIDs to alleviate bladder spasms

    • Catheterization as needed.

  • Patient Education:

    • Signs and symptoms (S/s) and treatment.


Page 9: Benign Prostatic Hypertrophy (BPH)

  • Overview:

    • Common disease in aging men

    • Slow enlargement of the prostate due to hypertrophy and hyperplasia, compressing the urethra.


Page 10: Assessment Findings in BPH

  • Storage Symptoms:

    • Frequency

    • Urgency

    • Nocturia

    • Incontinence

  • Voiding Symptoms:

    • Weak stream

    • Dribbling

    • Dysuria

    • Straining

  • Uncommon Symptoms:

    • Fever with dysuria

    • Urinary retention


Page 11: Diagnosis of BPH

  • Diagnostic Tests:

    • UA: normal in uncomplicated BPH

      • Pyuria indicates UTI

      • Hematuria may suggest cancer

    • PSA: elevated levels indicate potential issues and can aid in discussing treatment.

    • Volume charting: record frequency and volume of voiding for three days.


Page 12: Nursing Interventions for BPH

  • Medications:

    • First line treatment: focus on avoiding retention, shrinking the gland, and relaxing smooth muscle

  • Catheterization: Temporary urinary or straight catheterization if needed.


Page 13: Patient Education for BPH

  • Behavioral Modifications:

    • Reduce fluids at night.

    • Limit caffeine and alcohol

    • Avoid or adjust timing of diuretics/medications that may increase urinary retention.


Page 14: Pharmacology - Alpha-Blockers

  • Examples:

    • Tamsulosin & Terazosin: smooth muscle relaxers.

    • Initial therapy for most patients, effective within days.

    • "First-dose effect": Increased risk of falls, fractures, and head trauma.

    • Medications must be titrated; know drug class, MOA, and side effects.


Page 15: Pharmacotherapy - 5-Alpha Reductase Inhibitors

  • Examples:

    • Finasteride & Dutasteride

    • Effectively reduce prostate size and symptoms related to acute urinary retention.

    • PSA decreases by 50% but may obscure prostate cancer diagnosis.

    • Monitor for potential side effects like sexual dysfunction in 5-10% of patients.


Page 16: BPH Surgical & Invasive Procedures

  • Transurethral Resection of the Prostate (TURP):

    • Insert scope via urethra; standard procedure for prostate sizes < 80g.

    • Excellent resolution of LUTS, but increases risk of bleeding and ejaculatory dysfunction.

Other Procedures

  • Urethral stents for narrowing areas.

  • Prostatectomy: removal of the inner portion of the prostate.


Page 17: BPH Surgical Management

  • Most Common Surgical Procedure: Transurethral resection of the prostate (TURP).


Page 18: Post-op Considerations for TURP

  • Monitor for hemorrhage and perform continuous bladder irrigation.

  • Assess for TURP syndrome (transurethral resection syndrome).

  • Provide instructions for discharge and manage bladder spasms.


Page 19: TURP Syndrome

  • Definition: Excessive fluid load causing electrolyte shifts and associated symptoms due to absorption of irrigation fluid.

  • Can lead to complications such as hyponatremia and hypervolemia.


Page 20: Discharge Instructions Post-TURP

  • Avoid straining for bowel movements for 6 weeks (use stool softener).

  • Maintain catheter hygiene and recognize abnormal signs.

  • Engage in Kegel exercises for bladder control, avoid lifting > 5lbs for 6 weeks.

  • Resume sexual activity in 3-4 weeks; report any abnormal symptoms to the healthcare provider.


Page 21: Continuous Bladder Irrigation (CBI)

  • Purpose: Flush blood clots or debris from the bladder post-surgery.

  • Utilizes a triple-lumen catheter and maintains continuous output; urine should appear pink to clear.


Page 22: Indications for CBI

  • Post TURP and bladder surgery; can also be used for chemotherapy applications and to dissolve bladder stones.


Page 23: Nursing Management of CBI

  • Monitor and titrate to maintain appropriate urine clarity; intervene if obstructions occur (notify MD if unable to relieve).


Page 24: Prostate Cancer Overview

  • Characteristics: Slow-growing malignancy, most commonly adenocarcinomas.

  • Typically arises from the outer area of the prostate and can metastasize to lymphatic and vascular systems.


Page 25: Causes of Prostate Cancer

  • Risk Factors:

    • Age

    • Exposure to heavy metals

    • Smoking

    • High-fat diet

    • Obesity

    • African American descent

    • Family history

    • Sexually transmitted infections (STIs).


Page 26: Screening for Prostate Cancer

  • Methods:

    • PSA levels (initial exam at age 40); >4 requires follow-up.

    • DRE performed alongside baseline PSA to detect nodules or abnormalities.


Page 27: Diagnosis of Prostate Cancer

  • Diagnostic Tools:

    • PSA testing, DRE, transrectal ultrasound (TRUS) for biopsy.


Page 28: Prostate Cancer Assessment

  • Early Symptoms: Often asymptomatic but may present with hard nodules or painless hematuria in advanced disease.

  • Late Symptoms: Weight loss, urinary obstruction, and bone pain.


Page 29: Staging of Prostate Cancer

  • Stages:

    • Stage I: Localized tumor

    • Stage II: Tumor extended

    • Stage III: Local metastasis

    • Stage IV: Distant metastasis.


Page 30: Treatment Options for Prostate Cancer

  • Options:

    • Active surveillance, hormone therapy, chemotherapy, radiation (internal/external), proton therapy, prostatectomy.


Page 31: Active Surveillance

  • Close monitoring; treatment only if disease advances.

  • Regular PSA and DRE requirement for ongoing assessment.


Page 32: Chemotherapy for Prostate Cancer

  • Utilized when hormone therapy fails; not curative, but may improve survival rates in non-androgen-dependent cancers.


Page 33: Radiation Therapy – External

  • Administered to shrink tumors and reduce metastasis, typically in short sessions over several weeks.


Page 34: Radiation Therapy – Internal

  • Method: Radioactive seed implants into the prostate; minimal radiation exposure outside of the gland in the immediate aftermath.


Page 35: Radiation Therapy - Internal Continued

  • Patient Care: Monitor for complications like rectal inflammation, bleeding, and urinary issues; safeguard against exposure to vulnerable populations.


Page 36: Proton Therapy

  • Offers fewer side effects, is painless, and leaves surrounding tissues unharmed.

  • High survival rates at four years.


Page 37: Prostatectomy

  • Types of Approaches: Suprapubic, retropubic, and perineal.

  • Surgical removal of the prostate tissue for treatment.


Page 38: Clinical Judgment Question

  • Mr. Rodriguez: Identifying symptoms related to benign prostatic hyperplasia, including:

    • B. Incomplete emptying

    • D. Hesitancy

    • E. Intermittent urinary stream


Page 39: Nursing Care Post-Prostatectomy

  • Preoperative: Bowels preparation and clear liquid diet.

  • Postoperative Monitoring: Check for urine leaks, hemorrhage, and infection.


Page 40: Men's Health - Male Reproductive Problems

  • Critical health concerns regarding male reproductive disorders.


Page 41: Testicular Cancer

  • Self-Examination: Monthly testicular self-exam recommended

  • Types: Germinal and nongerminal cancers.

  • Symptoms: Painless enlargement, heaviness, inguinal pain, metastasis signs (back ache, weight loss).


Page 42: Testicular Self-Examination

  • Guidelines for self-examinations: check after showering, roll between fingers, look for lumps, and consult a doctor for abnormalities.


Page 43: Orchitis

  • Definition: Inflammation of one or both testicles; can be caused by various organisms.

  • Symptoms: Pain, fever, nausea/vomiting.


Page 44: Diagnosis and Treatment of Orchitis

  • Diagnosis: STI screening, UA, ultrasound to rule out torsion.

  • Treatment: Antibiotics (if bacterial), rest, scrotal support.


Page 45: Epididymitis

  • Symptoms: Pain and swelling in the back of the testicle, possible enlarged testes.

  • Diagnostic tests include UA, CBC, and STI testing.


Page 46: Treatment for Epididymitis

  • Management: Targeted antibiotics based on organism identification, bed rest, and scrotal elevation.


Page 47: Testicular Torsion

  • Definition: Twisting of the spermatic cord, leading to acute pain and blood flow loss to the testicle.

  • Diagnosis: Typically history of trauma, confirmed via ultrasound.


Page 48: Treatment of Testicular Torsion

  • Surgical Intervention: Urgent untwist of the testicle and suture cord to prevent re-torsion and preserve fertility.


Page 49: Warning Signs for Testicular Issues

  • Important symptoms include sudden testicular pain, swelling, and redness, requiring immediate medical attention.


Page 50: Erectile Dysfunction - Impotence

  • Definition: Inability to achieve or maintain an erection adequate for sexual intercourse, affecting a significant portion of men aged 40-70.


Page 51: Causes of Erectile Dysfunction

  • Psychogenic Factors: Include anxiety, depression, and relationship issues.

  • Organic Factors: Include cardiovascular diseases, diabetes, and certain medications.


Page 52: Diagnosis and Treatment of Erectile Dysfunction

  • Diagnosis: History and physicals, sleep studies.

  • Treatment Options: Medications (e.g., sildenafil, alprostadil) and mechanical devices.


Page 53: Priapism

  • Definition: Prolonged erection lasting 4-6 hours; can lead to severe complications if untreated.

  • Treatment: Oral medications, aspiration, and potentially surgery.


Page 54: Bladder Cancer

  • Overview: Arises from various sources, predominantly affects men.

  • Risk Factors: Smoking, chemical exposure, and radiation.


Page 55: Signs of Bladder Cancer

  • Primary Symptom: Visible, painless hematuria; other symptoms include urgency, frequency, and potential pain.


Page 56: Diagnostic Testing for Bladder Cancer

  • Cystoscopy: Key tool for visual inspection and biopsy of suspicious lesions.


Page 57: Treatment Options for Bladder Cancer

  • Methods Include: Radiation therapy, chemotherapy, urinary diversion, and cystectomy as necessary.


Page 58: Chemical and Surgical Treatments

  • Intravesical Chemotherapy: Concentrated treatment instilled into the bladder.

  • Surgical Interventions: Include transurethral resections and cystectomies.


Page 59: Postoperative Management

  • Key Focus Areas: Monitor urine output, vital signs, stoma assessment, and hydration management post-surgery.


Page 60: Percutaneous Nephrostomy

  • Indications: Used for kidney obstructions from tumors or calculi.

  • Consists of inserting a nephrostomy tube to relieve obstruction.

robot